BSE filing, NSE: SOTL. Summary written from the filing by ALFA Finder's alert engine.
Savita Oil Technologies Ltd: key numbers
- Share price
- ₹671.75
- Market cap
- ₹4,606 Cr
- Revenue (annual)
- ₹4,363 Cr
- Net profit (annual)
- ₹181.8 Cr
- P/E (TTM)
- 11.1×Sector 18.3×
- Promoter holding
- 68.93%+0.00% QoQ
- FII holding
- 1.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Savita Oil Technologies Ltd
All →Savita Oil Technologies Other Announcement
Savita Oil Technologies Ltd filed its quarterly dematerialization compliance certificate as mandated under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Savita Oil Technologies Price Movement Clarification
Savita Oil Technologies clarified that recent volume and price increases are purely market-driven. The company confirmed no material undisclosed information exists under Regulation 30.
Savita Oil Technologies Promoter Buying: ₹3.76 Cr
Savita Oil Technologies promoters Siddharth Mehra and Reshma Gautam Mehra acquired equity shares worth Rs. 3.76 Crore via market purchases. These transactions were disclosed under PIT Regulation 7(2).
- Value
- ₹3.76 Cr
- Promoter stake change
- +0.08%
Savita Oil Technologies Promoter Buying
Promoter Siddharth Mehra acquired 25,830 equity shares of Savita Oil Technologies Limited from the open market, increasing his stake by 0.04%.
- Promoter stake change
- +0.04%
Savita Oil Technologies Promoter Selling
Promoter Gautam N. Mehra sold 46,000 shares of Savita Oil Technologies Limited via the open market, reducing his promoter group stake by 0.07%.
- Promoter stake change
- -0.07%
Savita Oil Technologies Investor Presentation: Key Takeaways
Savita Oil reported record Q1 FY27 results with 49% YoY revenue growth and a 435% surge in PBT. Strategy focuses on high-margin Ester-based fluids and new-age thermal management solutions.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.